JP2017500584A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017500584A5 JP2017500584A5 JP2016549205A JP2016549205A JP2017500584A5 JP 2017500584 A5 JP2017500584 A5 JP 2017500584A5 JP 2016549205 A JP2016549205 A JP 2016549205A JP 2016549205 A JP2016549205 A JP 2016549205A JP 2017500584 A5 JP2017500584 A5 JP 2017500584A5
- Authority
- JP
- Japan
- Prior art keywords
- assay
- biological sample
- hmwk
- autoimmune disease
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 31
- 102000002261 High-Molecular-Weight Kininogen Human genes 0.000 claims 21
- 108010000487 High-Molecular-Weight Kininogen Proteins 0.000 claims 21
- 239000012472 biological sample Substances 0.000 claims 20
- 208000023275 Autoimmune disease Diseases 0.000 claims 16
- 238000003556 assay Methods 0.000 claims 12
- 239000000523 sample Substances 0.000 claims 7
- 238000002965 ELISA Methods 0.000 claims 6
- 239000011230 binding agent Substances 0.000 claims 6
- 206010009900 Colitis ulcerative Diseases 0.000 claims 4
- 208000011231 Crohn disease Diseases 0.000 claims 4
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 4
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 4
- 238000001514 detection method Methods 0.000 claims 3
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 claims 3
- 238000003119 immunoblot Methods 0.000 claims 3
- 239000003112 inhibitor Substances 0.000 claims 3
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims 3
- 210000002966 serum Anatomy 0.000 claims 3
- 238000001262 western blot Methods 0.000 claims 3
- 102000003827 Plasma Kallikrein Human genes 0.000 claims 2
- 108090000113 Plasma Kallikrein Proteins 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 239000013068 control sample Substances 0.000 claims 1
- 230000007423 decrease Effects 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 229940126155 plasma kallikrein inhibitor Drugs 0.000 claims 1
- 230000002250 progressing effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361893542P | 2013-10-21 | 2013-10-21 | |
| US61/893,542 | 2013-10-21 | ||
| PCT/US2014/061242 WO2015061182A1 (en) | 2013-10-21 | 2014-10-17 | Diagnosis and treatment of autoimmune diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020018129A Division JP7157089B2 (ja) | 2013-10-21 | 2020-02-05 | 自己免疫疾患の診断と治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017500584A JP2017500584A (ja) | 2017-01-05 |
| JP2017500584A5 true JP2017500584A5 (enExample) | 2017-11-30 |
| JP6657098B2 JP6657098B2 (ja) | 2020-03-04 |
Family
ID=52993412
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016549205A Active JP6657098B2 (ja) | 2013-10-21 | 2014-10-17 | 自己免疫疾患の診断と治療 |
| JP2020018129A Active JP7157089B2 (ja) | 2013-10-21 | 2020-02-05 | 自己免疫疾患の診断と治療 |
| JP2022161469A Active JP7541560B2 (ja) | 2013-10-21 | 2022-10-06 | 自己免疫疾患の診断と治療 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020018129A Active JP7157089B2 (ja) | 2013-10-21 | 2020-02-05 | 自己免疫疾患の診断と治療 |
| JP2022161469A Active JP7541560B2 (ja) | 2013-10-21 | 2022-10-06 | 自己免疫疾患の診断と治療 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US10101344B2 (enExample) |
| EP (2) | EP3913364A1 (enExample) |
| JP (3) | JP6657098B2 (enExample) |
| KR (3) | KR102485948B1 (enExample) |
| CN (2) | CN105874332B (enExample) |
| AU (4) | AU2014340449B2 (enExample) |
| BR (1) | BR112016008975B1 (enExample) |
| CA (1) | CA2927695C (enExample) |
| DK (1) | DK3060908T3 (enExample) |
| ES (1) | ES2873204T3 (enExample) |
| IL (4) | IL293948A (enExample) |
| PL (1) | PL3060908T3 (enExample) |
| PT (1) | PT3060908T (enExample) |
| WO (1) | WO2015061182A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111044725B (zh) * | 2013-01-20 | 2024-03-29 | 武田药品工业株式会社 | 缓激肽介导的病症的评估和治疗 |
| KR102521947B1 (ko) | 2013-10-21 | 2023-04-14 | 다케다 파머수티컬 컴패니 리미티드 | 혈장 칼리크레인 시스템 바이오마커를 결정하기 위한 검정법 |
| AU2014340449B2 (en) | 2013-10-21 | 2019-10-31 | Takeda Pharmaceutical Company Limited | Diagnosis and treatment of autoimmune diseases |
| KR102698737B1 (ko) * | 2015-10-19 | 2024-08-27 | 다케다 파머수티컬 컴패니 리미티드 | 절단된 고분자량 키니노겐의 검출을 위한 면역검정법 |
| US11815516B2 (en) * | 2016-09-16 | 2023-11-14 | Takeda Pharmaceutical Company Limited | Protein biomarkers for diseases associated with the contact activation system |
| KR200490846Y1 (ko) | 2019-04-09 | 2020-01-13 | 이대호 | 각도조절 브라켓 |
| WO2021202948A2 (en) * | 2020-04-04 | 2021-10-07 | Dyax Corp. | Plasma kallikrein inhibitors and uses thereof for treating acute respiratory distress syndrome |
| KR20230050770A (ko) | 2021-10-08 | 2023-04-17 | 김경민 | 발로 열 수 있는 반려동물 울타리 |
| JP2025522757A (ja) * | 2022-06-30 | 2025-07-17 | 武田薬品工業株式会社 | ラナデルマブ治療のためのタンパク質バイオマーカー |
Family Cites Families (75)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| CA1312564C (en) | 1985-07-12 | 1993-01-12 | Robert W. Colman | Monoclonal antibodies to human plasma prekallikrein and methods of preparing and using same |
| US4908431A (en) | 1986-01-22 | 1990-03-13 | Temple University-Of The Commonwealth System Of Higher Education | Monoclonal antibodies to human kininogen and methods of preparing same |
| US5047323A (en) | 1986-01-22 | 1991-09-10 | Temple University Of The Commonwealth System Of Higher Education | Method for detecting human kininogen using monoclonal antibodies thereto |
| US5260203A (en) | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
| US4881175A (en) | 1986-09-02 | 1989-11-14 | Genex Corporation | Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| JPS63185398A (ja) | 1986-09-10 | 1988-07-30 | Nippon Zoki Pharmaceut Co Ltd | 生理活性物質測定法 |
| US4882272A (en) | 1986-10-01 | 1989-11-21 | Temple University - Of The Commonwealth System Of Higher Education | High molecular weight kininogen assay |
| US5025796A (en) | 1988-12-01 | 1991-06-25 | The United States Of America As Represented By The Department Of Health And Human Services | Apparatus and methods for determining in vivo response to thermal stimulation in in an unrestrained subject |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| WO1992022653A1 (en) | 1991-06-14 | 1992-12-23 | Genentech, Inc. | Method for making humanized antibodies |
| US5472945A (en) | 1991-08-13 | 1995-12-05 | Temple University- Of The Commonwealth System Of Higher Education | Modulation of blood pressure and inhibition of platelet activation with kininogen fragment |
| US5827690A (en) | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
| CA2180950C (en) | 1994-01-11 | 2005-03-29 | William Markland | Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof |
| US6057287A (en) | 1994-01-11 | 2000-05-02 | Dyax Corp. | Kallikrein-binding "Kunitz domain" proteins and analogues thereof |
| ATE496288T1 (de) | 1995-10-11 | 2011-02-15 | Luminex Corp | Gleichzeitige mehrfachanalyse klinischer proben |
| JPH1084995A (ja) | 1996-09-12 | 1998-04-07 | Nippon Zoki Pharmaceut Co Ltd | 血液凝固第ｘｉｉ因子活性化法 |
| US5789261A (en) | 1996-10-30 | 1998-08-04 | Temple University Of The Commonwealth System Of Higher Education | Solid phase immunoassay |
| US6242210B1 (en) | 1997-05-20 | 2001-06-05 | Actinova Limited | Treatment of bacterial infections |
| CA2290485C (en) | 1997-05-21 | 2008-08-05 | Biovation Limited | Method for the production of non-immunogenic proteins |
| EP1051432B1 (en) | 1998-12-08 | 2007-01-24 | Biovation Limited | Method for reducing immunogenicity of proteins |
| JP4346798B2 (ja) | 1999-08-19 | 2009-10-21 | 協和メデックス株式会社 | Ｈｃｖコア抗原の検出または定量方法およびそれに用いる検出または定量試薬。 |
| US6994852B1 (en) | 1999-11-12 | 2006-02-07 | Temple University-Of The Commonwealth System Of Higher Education | Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5 |
| US7067713B2 (en) | 2000-01-31 | 2006-06-27 | Pharming Intellectual Property B.V. | C1 Inhibitor produced in the milk of transgenic non-human mammals |
| US7678541B2 (en) | 2000-11-21 | 2010-03-16 | Hologic, Inc. | Methods and compositions for the detection of a nucleic acid using a non-invasive cleavage reaction |
| JP2002221519A (ja) | 2001-01-29 | 2002-08-09 | Sysmex Corp | 抗凝固剤およびそれを用いた抗凝固剤処理方法 |
| US20040152633A1 (en) | 2001-05-31 | 2004-08-05 | Jorgensen Marianne Ulrich | Kunitz-type sequences and polypeptides |
| ATE477280T1 (de) | 2001-06-28 | 2010-08-15 | Domantis Ltd | Doppelspezifischer ligand und dessen verwendung |
| US6913900B2 (en) | 2001-08-29 | 2005-07-05 | Nippon Zoki Pharmaceutical Co., Ltd. | Plasma prekallikrein activation and kallikrein production assay |
| JP4106888B2 (ja) | 2001-09-19 | 2008-06-25 | カシオ計算機株式会社 | 液晶表示装置および携帯端末装置 |
| US8148171B2 (en) | 2001-10-09 | 2012-04-03 | Luminex Corporation | Multiplexed analysis of clinical specimens apparatus and methods |
| US7064107B2 (en) | 2002-06-07 | 2006-06-20 | Dyax Corp. | Prevention and reduction of blood loss |
| WO2004001065A2 (en) | 2002-06-24 | 2003-12-31 | Cornell Research Foundation, Inc. | Exhaustive selection or rna aptamers against complex targets |
| US20070003552A1 (en) | 2002-07-09 | 2007-01-04 | Gebbink Martijn F B | Cross-beta structure comprising amyloid binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fibril formation and for modulating cross-beta structure-mediated toxicity and method for interfering with blood coagulation |
| EP1556162A1 (en) | 2002-11-01 | 2005-07-27 | McMaster University | Multicomponent protein microarrays |
| WO2005024042A2 (en) | 2003-09-04 | 2005-03-17 | The Regents Of The University Of California | Aptamers and methods for their in vitro selection and uses thereof |
| JP5543052B2 (ja) | 2003-11-22 | 2014-07-09 | 株式会社テクノメディカ | アプタマーを用いた標的分子の検出方法 |
| EP1598428A1 (en) | 2004-05-18 | 2005-11-23 | Georg Dewald | Methods and kits to detect Hereditary angioedema type III |
| AU2005271523B2 (en) | 2004-08-03 | 2011-09-15 | Dyax Corp. | hk1-binding proteins |
| US7235530B2 (en) | 2004-09-27 | 2007-06-26 | Dyax Corporation | Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
| WO2006040153A2 (en) | 2004-10-13 | 2006-04-20 | Ablynx N.V. | Single domain camelide anti -amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenarative neural diseases such as alzheimer's disease |
| EP1888640B1 (en) | 2005-05-18 | 2012-03-14 | Ablynx N.V. | Improved nanobodies against tumor necrosis factor-alpha |
| CA2635589C (en) | 2005-12-29 | 2017-01-17 | Dyax Corp. | Protease inhibition |
| EP2051707B1 (en) | 2006-07-31 | 2013-07-17 | Activesite Pharmaceuticals, Inc. | Inhibitors of plasma kallikrein |
| WO2008064336A2 (en) * | 2006-11-22 | 2008-05-29 | Inivitrogen Corporation | Autoimmune disease biomarkers |
| WO2008100791A1 (en) | 2007-02-16 | 2008-08-21 | Rules-Based Medicine, Inc. | Methods and kits for the diagnosis of sickle cell |
| US20090075887A1 (en) * | 2007-08-21 | 2009-03-19 | Genzyme Corporation | Treatment with Kallikrein Inhibitors |
| WO2009053050A1 (en) | 2007-10-22 | 2009-04-30 | Georg Dewald | Disorders of vasoregulation and methods of diagnosing them |
| KR20110057086A (ko) * | 2008-07-07 | 2011-05-31 | 니폰 조키 세야쿠 가부시키가이샤 | 섬유근 통증의 검사법 |
| JP2012507723A (ja) * | 2008-11-03 | 2012-03-29 | シェーリング コーポレイション | 炎症性腸疾患生物マーカーおよび関連治療方法 |
| US20110318359A1 (en) | 2008-12-02 | 2011-12-29 | Feener Edward P | Method for reducing blood pressure using inhibitors of plasma kallikrein |
| CN102307594A (zh) | 2009-01-06 | 2012-01-04 | 戴埃克斯有限公司 | 用激肽释放酶抑制剂治疗粘膜炎 |
| FR2942233B1 (fr) | 2009-02-19 | 2015-03-13 | Lfb Biotechnologies | Moyens pour la purification d'une proteine du plasma sanguin, et procedes pour sa mise en oeuvre |
| KR101077275B1 (ko) * | 2009-05-07 | 2011-10-27 | 한국기초과학지원연구원 | 당단백질의 당쇄화를 이용한 암 진단 방법 |
| JP5299179B2 (ja) * | 2009-09-02 | 2013-09-25 | 株式会社リコー | 画像形成装置 |
| JO3244B1 (ar) | 2009-10-26 | 2018-03-08 | Amgen Inc | بروتينات ربط مستضادات il – 23 البشرية |
| CA2783801A1 (en) | 2009-12-18 | 2011-06-23 | Activesite Pharmaceuticals, Inc. | Prodrugs of inhibitors of plasma kallikrein |
| US9206123B2 (en) * | 2009-12-18 | 2015-12-08 | Activesite Pharmaceuticals, Inc. | Prodrugs of inhibitors of plasma kallikrein |
| PL3459564T3 (pl) | 2010-01-06 | 2022-04-19 | Takeda Pharmaceutical Company Limited | Białka wiążące kalikreinę osocza |
| EP2593121A2 (en) * | 2010-07-13 | 2013-05-22 | University Of Rochester | THE cAMP/PKA/HDAC5 PATHWAY AND USES THEREOF |
| EP2645932B1 (en) | 2010-12-02 | 2016-03-02 | Becton, Dickinson and Company | Blood collection devices containing blood stabilization agent |
| KR102502293B1 (ko) * | 2011-01-06 | 2023-02-21 | 다케다 파머수티컬 컴패니 리미티드 | 혈장 칼리크레인 결합 단백질 |
| WO2012170947A2 (en) | 2011-06-10 | 2012-12-13 | Isis Pharmaceuticals, Inc. | Methods for modulating factor 12 expression |
| CA2838984A1 (en) | 2011-06-10 | 2012-12-13 | Isis Pharmaceuticals, Inc. | Methods for modulating kallikrein (klkb1) expression |
| CN111044725B (zh) | 2013-01-20 | 2024-03-29 | 武田药品工业株式会社 | 缓激肽介导的病症的评估和治疗 |
| RU2015136025A (ru) | 2013-02-01 | 2017-03-06 | Бектон, Дикинсон энд Кампани | Устройства для сбора крови, содержащие добавки, ингибирующие контактный путь свертывания крови |
| AU2014340449B2 (en) | 2013-10-21 | 2019-10-31 | Takeda Pharmaceutical Company Limited | Diagnosis and treatment of autoimmune diseases |
| KR102521947B1 (ko) | 2013-10-21 | 2023-04-14 | 다케다 파머수티컬 컴패니 리미티드 | 혈장 칼리크레인 시스템 바이오마커를 결정하기 위한 검정법 |
| KR20220107077A (ko) | 2014-01-21 | 2022-08-01 | 다케다 파머수티컬 컴패니 리미티드 | 혈장 칼리크레인 결합 단백질 및 유전성 혈관부종을 치료하는 데 있어서의 이의 용도 |
| KR102698737B1 (ko) | 2015-10-19 | 2024-08-27 | 다케다 파머수티컬 컴패니 리미티드 | 절단된 고분자량 키니노겐의 검출을 위한 면역검정법 |
| MX2018007493A (es) | 2015-12-15 | 2018-09-18 | Dyax Corp | Ensayo de cuantificacion de peptido para diferenciar quininogeno de alto peso molecular (hmwk) de longitud completa y hmwk escindido. |
| IL295166A (en) * | 2020-01-28 | 2022-09-01 | Orgenesis Inc | Process and system for acellular therapy |
-
2014
- 2014-10-17 AU AU2014340449A patent/AU2014340449B2/en active Active
- 2014-10-17 CN CN201480069823.8A patent/CN105874332B/zh active Active
- 2014-10-17 PT PT148550023T patent/PT3060908T/pt unknown
- 2014-10-17 DK DK14855002.3T patent/DK3060908T3/da active
- 2014-10-17 IL IL293948A patent/IL293948A/en unknown
- 2014-10-17 IL IL284969A patent/IL284969B/en unknown
- 2014-10-17 CN CN201910994046.2A patent/CN110658337B/zh active Active
- 2014-10-17 EP EP21158440.4A patent/EP3913364A1/en active Pending
- 2014-10-17 KR KR1020217026950A patent/KR102485948B1/ko active Active
- 2014-10-17 US US15/030,790 patent/US10101344B2/en active Active
- 2014-10-17 JP JP2016549205A patent/JP6657098B2/ja active Active
- 2014-10-17 CA CA2927695A patent/CA2927695C/en active Active
- 2014-10-17 EP EP14855002.3A patent/EP3060908B1/en active Active
- 2014-10-17 KR KR1020167013312A patent/KR102295623B1/ko active Active
- 2014-10-17 WO PCT/US2014/061242 patent/WO2015061182A1/en not_active Ceased
- 2014-10-17 ES ES14855002T patent/ES2873204T3/es active Active
- 2014-10-17 BR BR112016008975-8A patent/BR112016008975B1/pt active IP Right Grant
- 2014-10-17 PL PL14855002T patent/PL3060908T3/pl unknown
- 2014-10-17 KR KR1020237000230A patent/KR102665705B1/ko active Active
-
2016
- 2016-04-19 IL IL245206A patent/IL245206B/en active IP Right Grant
-
2018
- 2018-09-14 US US16/131,781 patent/US10648990B2/en active Active
-
2020
- 2020-01-21 AU AU2020200423A patent/AU2020200423B2/en active Active
- 2020-02-05 JP JP2020018129A patent/JP7157089B2/ja active Active
- 2020-04-15 US US16/849,492 patent/US12061206B2/en active Active
- 2020-06-14 IL IL275368A patent/IL275368B/en unknown
-
2022
- 2022-06-29 AU AU2022204649A patent/AU2022204649B2/en active Active
- 2022-10-06 JP JP2022161469A patent/JP7541560B2/ja active Active
-
2024
- 2024-11-19 AU AU2024266697A patent/AU2024266697A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017500584A5 (enExample) | ||
| JP2016536012A5 (enExample) | ||
| JP2017524130A5 (enExample) | ||
| Louis et al. | Extra-pulmonary complications in SARS-CoV-2 infection: a comprehensive multi organ-system review | |
| Villalba et al. | Interferon gamma, TGF-β1 and RANTES expression in upper airway samples from SARS-CoV-2 infected patients | |
| Erickson et al. | Serum amyloid A: an ozone-induced circulating factor with potentially important functions in the lung-brain axis | |
| CY1121872T1 (el) | Αξιολογηση, δοκιμασιες και θεραπεια των pkal-μεσολαβουμενων διαταραχων | |
| Hisada et al. | Circulating tissue factor‐positive extracellular vesicles and their association with thrombosis in different diseases | |
| Tomerak et al. | Systemic inflammation in COVID‐19 patients may induce various types of venous and arterial thrombosis: a systematic review | |
| JP2010516678A5 (enExample) | ||
| WO2012017466A8 (en) | Use of hmgb1 as a biological marker of bowel inflammatory conditions, non-invasive method for its detection in fecal samples and kit thereof | |
| Boccatonda et al. | Long-term hypercoagulability, endotheliopathy and inflammation following acute SARS-CoV-2 infection | |
| Jia et al. | Rho kinase mediates Porphyromonas gingivalis outer membrane vesicle-induced suppression of endothelial nitric oxide synthase through ERK1/2 and p38 MAPK | |
| WO2013009703A8 (en) | Antibodies, kit and method for detecting amyloid beta oligomers | |
| JP2017505897A5 (enExample) | ||
| JP2020091296A5 (enExample) | ||
| EA201490105A1 (ru) | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности | |
| BR112017004883A2 (pt) | ensaio de diagnóstico baseado em fragmento de rgma | |
| JP2006311860A5 (enExample) | ||
| JP2016519761A5 (enExample) | ||
| Rottenstreich et al. | Assessment of the procoagulant potential after laparoscopic sleeve gastrectomy: a potential role for extended thromboprophylaxis | |
| Zhang et al. | Proteomic analysis associated with coronary artery dilatation caused by Kawasaki disease using serum exosomes | |
| BR112015021507A8 (pt) | métodos e composições para o diagnóstico de pré-eclampsia em uma mulher grávida e kit de ensaio de diagnóstico | |
| Brochado et al. | HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients | |
| Huckriede et al. | Markers of NETosis and DAMPs are altered in critically ill COVID-19 patients |